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Abstract The role of dendritic cells in vitiligo is still
unclear. Few studies have provided contradictory results
about their quantitative variation and no data exist con-
cerning their immunophenotypical distribution in diseased
skin. The purpose of our study was to analyze the presence,
the distribution, the immunophenotypical markers and the
effects of nb-UVB therapy on dendritic cells in non-
lesional, perilesional, and lesional vitiligo skin. Punch-
biopsies of 6 mm were taken from lesional, perilesional,
and non-lesional skin of 12 patients affected by non-
segmental vitiligo, treated with nb-UVB. An immunohis-
tochemical and an ultrastructural analysis were performed.
Immunohistochemical and ultrastructural analysis showed
both quantitative and qualitative modifications of Langer-
hans cells. Nb-UVB therapy, one of the most effective
treatments for the disease, was able to reduce the Langer-
hans cells number and to redistribute main dendritic sub-
sets. This study underlines the importance of dendritic
cells, Langerhans cells in particular, in non-segmental
vitiligo, in its pathogenesis and in its better therapeutical
approach.
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Introduction
Vitiligo is an acquired hypomelanotic disease characterized
by loss of melanocytes that can be observed in 0.5–2% of
the population [8, 20]. Despite much research, its patho-
physiologic mechanism is not fully clear. There are three
main hypotheses that consider different factors as causes of
melanocytes’ destruction: autoimmune, biochemical, and
neuronal theory. The latter is still considered as the most
suitable one to explain the pathogenesis of segmental vit-
iligo (a localized type of vitiligo with a segmental distri-
bution); it suggests the release of some chemical mediators
from peripheral nerve endings as a cause of the decreased
melanin production [6]. The autoimmune hypothesis pro-
poses that a breakdown of tolerance, with activation of
both the humoral and the cellular arm of immune system,
may be the cause of melanocytes destruction [13]. The
biochemical theory ascribes the destruction of melanocytes
to autocytotoxic metabolites, which derive from the syn-
thesis of melanin. Several studies prove the presence of
oxidative stress and the accumulation of free radicals in the
epidermal layer of affected skin, and recently antioxidant
enzymes and lipid peroxidation have been detected in the
tissues of vitiligo patients [2, 4]. Le Poole et al. in 1993
worked out the ‘‘convergence theory’’, which suggests the
synergistic role of all the above-mentioned factors and cells
in the pathogenesis of vitiligo [9].
Recently, supported by the concept of ‘‘epidermal-
melanic unit’’ proposed by Fitzpatrick and Breathnach, a
new theory has been proposed: the eclectic hypothesis [5,
7]. Eclectic hypothesis considers vitiligo as the expression
of a change in the normal communication network,
involving melanocytes, keratinocytes, antigen-presenting
cells, mast cells, and fibroblasts. The formation of an
adverse microenvironment for the melanocytes survival
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has been related to growth factors, cytokines, inflammatory
mediators, and adhesion molecules [7].
The histopathological data on vitiligo could be useful to
find answers to many questions which are still unresolved.
As a lot of studies have provided contradictory results
about the quantitative variation of Langerhans cells in the
vitiligo-affected skin [12] and no previous data exist con-
cerning the immunophenotypical distributions of specific
markers of dendritic cells, we focused our attention on
defining the ultrastructural features of lesional, perilesion-
al, and non-lesional skin from vitiligo patients with a
similar clinical history concerning the lesions’ extension,
duration of the disease, and absence of autoimmunity. We
observed an increase of dendritic cells in lesional and
perilesional vitiligo skin, with ultrastructural alterations in
their mitochondria especially in perilesional skin [17]. The
purpose of our study was to evaluate the effects of nb-UVB
(narrow band-B ultraviolet)—at present one of the most
effective therapies for vitiligo—on dendritic cells in le-
sional and perilesional vitiligo skin [1, 10, 11].
Materials and methods
Punch-biopsies of 6 mm were taken from lesional, perile-
sional, and non-lesional skin of 12 patients affected by non-
segmental generalized vitiligo with a similar clinical history
(lesions extension, ongoing of the disease and absence of
circulating autoantibodies) (Table 1).
A written informed consensus was obtained from all
patients and procedures were carried out in accordance
with the ethical standards of the Committee on Human
Experimentation of the Department of the Dermatological
Science and the Declaration of Helsinki.
Each patient underwent three biopsies (from lesional,
perilesional, and non-lesional vitiligo skin) before and after
nb-UVB phototherapy (total-body exposure by 0.21 J/cm2
for body surface, three times a week for 2 months).
Lesional, perilesional and non-lesional skin are defined as
clinically affected skin (lesional), skin along the edge of
the white patch (perilesional) and clinically unaffected, the
normally pigmented skin (non-lesional).
All biopsies were divided in two parts in order to per-
form both immunohistochemical and ultrastructural study.
Immunohistochemical study
Immunostaining was carried out on each half of the six
punch-biopsies, we obtained from lesional, perilesional and
non-lesional vitiligo skin before and after nb-UVB expo-
sure, using an APAAP (alkaline-phosphatase–anti-alkaline-
phosphatase) method and mouse monoclonal anti-human
antibodies (MoAb) as primary reagents. All biopsies were
frozen at -80C and then 5-lm serial cryostat sections
were cut and fixed in ice-cold acetone for 4 min prior to
staining.
Thereafter, the sections were incubated with human
serum of AB group followed by primary MoAb for 2 h at
room temperature and avoiding light exposure. The sec-
tions were accurately washed and incubated for 40 min
with rabbit’s anti-mouse immunoglobulin antiserum
(RAM, 1:30) (Dako, Glostrup, Denmark) and processed
with the APAAP complex (1:50) (Laborometrics, Milan,
Italy). RAM/APAAP incubation was repeated twice to
improve the labeling. Binding of the complex was revealed
by hexazotized new fuchsin as a chromogenic substrate
(Merck, Darmstadt, Germany). The sections were then
counterstained with Mayer’s hematoxylin. Control sections
Table 1 Clinical data of
vitiligo patients
Patients Age Age of onset Biopsy site (lesional
and perilesional skin)
Biopsy site
(non-lesional skin)
n. 1 58 53 Hand Abdomen
n. 2 62 56 Abdomen Trunk
n. 3 46 41 Trunk Hand
n. 4 35 30 Trunk Trunk
n. 5 41 35 Hand Abdomen
n. 6 34 28 Hand Abdomen
n. 7 25 20 Trunk Hand
n. 8 19 15 Abdomen Trunk
n. 9 36 30 Hand Trunk
n. 10 37 32 Trunk Hand
n. 11 22 16 Abdomen Trunk
n. 12 43 39 Trunk Trunk
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were incubated with normal mouse IgG. The MoAbs used
in this study are summarized in Table 2.
Electron microscopy
Half of each biopsy obtained from non-nb-UVB-exposed
and nb-UVB-exposed skin, and from vitiligo lesional,
perilesional, and non-lesional skin was fixed in a mixture of
2% formaldehyde and 2.5% glutaraldehyde in 0.1 mmol/l
cacodylate buffer, pH 7.4, at 5C for 3 h, followed by
postfixation in 1% OsO4 in phosphate buffer, pH 7.4 at
room temperature for 2 h. The specimens were dehydrated
in a graded acetone series, passed through propylene-oxide
and embedded in Epon 812. A sequential number of semi-
thin sections were stained with uranylacetate, followed by
bismuth subnitrate or lead citrate, and examined in a Jeol
1010 (Tokyo, Japan) at 80 kV.
Results
Immunohistochemical analysis
A total of 432 sections were obtained and analyzed by
two examiners. Number and distribution (in epidermis and
dermis) of marked cells in three different fields of non-
exposed and nb-UVB-exposed vitiligo skin were studied.
The result of the count was expressed as an average value
for each MoAb apart. We proposed both the average
values of cells count distinguishing before and after
phototherapy (Table 3), and their percentage variations
(Table 4).
In non-lesional skin we did not report significant mod-
ifications of the expression of the proteins (both in the
epidermis and in the dermis) after nb-UVB phototherapy,
with the exception of anti-CD1a (reduction of 3% in the
epidermis and increased of 11% in the dermis) and anti-
HLA-DR (increased both in the epidermis and in the der-
mis (Figs. 1, 2a, b).
In perilesional vitiligo skin (Figs. 1, 2c, d) upon
nb-UVB, in the epidermis, CD1a and Langerin were
increased of 24 and 75%, respectively, while HLA-DR
showed a reduction of 50%. In the dermis the immuno-
phenotypical markers maintained the same distribution as
in vitiligo lesional skin, while the markers for CD1a and
HLA-DR, but not for Langerin, were reduced. Langerin
positive cells were reduced of 60% after treatment; there
was also a reduction of CD68 positive cells.
In the epidermis of lesional skin all MoAb were less
expressed after nb-UVB phototherapy with the exception
of anti-HLA-DR antibody. Particularly CD1a and Langerin
showed both a reduction of about 70% and they could be
considered as the quantitative distribution index of Lan-
gerhans cells, while the reductions of CD83 and CD86
were 43 and 57%, respectively. In the dermis, the markers
as CD1a, HLA-DR and Langerin, were more expressed
after phototherapy, about 40, 60 and 70%, respectively.
Upon nb-UVB treatment there was a decrease of CD68?
cells both in epidermis and dermis. CD68? cells in the
dermis of lesional skin underwent a minor depletion being
the 70% (Figs. 1, 2e, f).
Ultrastructural analysis
Before nb-UVB therapy, in non-lesional vitiligo skin we
did not find any relevant alterations. The basal keratino-
cytes showed a well differentiated phenotype and a normal
and well oriented cytoskeleton within their cytoplasm
(Fig. 3a). The anchoring fibrils were well preserved
(Fig. 3b). The epidermal-melanic unit was represented by a
steady number of melanocytes and keratinocytes and there
were signs of melanogenesis, as shown by the high member
of melanosomes in all phases of differentiation. Langer-
hans cells showed the typical indented nucleus and a rough
endoplasmic reticulum, Golgi apparatus and some mito-
chondria within the cytoplasm. The mitochondria were
more numerous in some cells than in others, with a well
preserved ultrastructure.
Table 2 Monoclonal antibodies used in this study
MoAb type Cellular subset selected MoAb meaning
CD1a APCa Non-peptide antigensc presentation to lymphocytes
HLA-DR APCb Peptide antigens presentation to lymphocytes
CD83 Langerhans cells Maturation marker
CD86 Dendritic cells Activation marker (co-stimulation complex B7)
Langerin Langerhans cells Non-peptide antigensc presentation to lymphocytes
CD68 Monocytes (including tissue macrophages) Endocytosis and/or lysosomal traffic
a APC: antigen-presenting cell, particularly Langerhans cells
b APC: antigen-presenting cell, particularly dendritic cells, macrophages and B lymphocytes
c Non-peptide antigens includes lipid and carbohydrate antigens
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The basal membrane in perilesional vitiligo skin
appeared well developed, with focal interruptions. The
epidermal cells of the basal and suprabasal layers presented
ultrastructural alterations of their mitochondria consistent
with the results of one of our previous work [17]. Lan-
gerhans cells of perilesional skin presented a tendency to
distribute in the suprabasal layer. They were numerous and
displayed rarefied chromatin in their nucleus with tendency
to lose their typical nuclear indentation. The mitochondria
of these cells appeared numerous and with ultrastructural
alterations, that consisted in rarefactions or disruption of
their membranes, till the total disappearance of the cristae
(Fig. 4a). Sometime, close to Golgi apparatus or close to
the cytoplasmic membrane was possible to appreciate the
presence of the Birbeck granules (Fig. 4b), which not
always reached the typical racket-like shape, as distinctive
feature of terminal differentiation.
In lesional vitiligo skin the basal membrane appeared
well preserved; basal and suprabasal keratinocytes pre-
sented no cytoskeletal alterations or reorganization of
Table 3 Statistical analysis of histologic evaluation before and after nb-UVB treatment
CD1a HLA-DR CD83 CD86 Langerin CD68
Epid Der Epid Der Epid Der Epid Der Epid Der Epid Der
Non-lesional skin
Before
Mean 6.2 1.8 1.5 6 4 1.5 1.5 0 2 0 0 0
SD 0.1 0.2 2.1 2.8 2.8 0.8 2.1 0 2.8 0 0 0
After
Mean 6 2 2 9 4 1.5 1.5 0 3 0 0 0
SD 0.7 0.8 0.7 7.7 1.4 0.3 1 0 5.6 0 0 0
p value 0.29 0.14 0.01 0.01 0.34 0.18
Perilesional skin
Before
Mean 9.6 3.3 6.6 6.3 2 0.6 1.6 0 4 4 3 5.2
SD 0.7 5.6 1.4 8.5 2.8 1.1 2.8 0 2.7 2.7 3.3 5.3
After
Mean 12 4.5 3.5 9 0 0 1 0 7 1 0 0
SD 4.2 0.7 0.7 7 0 0 1.4 0 5.6 0 0 0
p value 0.24 0.33 0.01 0.47 0.25 0.21 0.31 0.29 0.07 0.1 0.09
Lesional skin
Before
Mean 13 5.8 3.7 7.3 5.3 3 2.3 0 11 1.5 1.5 3.3
SD 2.2 4.3 1.7 3.7 6.8 2.5 2.5 0 2.5 1.5 2.6 4.1
After
Mean 4 8 4 11.5 3 5 1 0.5 3.5 2.5 0 1
SD 1.4 5.6 5.6 7.8 4.2 7.1 1.4 0.7 0.7 3.5 0 1.4
p value 0.008 0.34 0.46 0.39 0.35 0.29 0.25 0.25 0.01 0.37 0.19 0.21
Epid Epidermis, Der dermis
Table 4 The percentage variations (each value is expressed as percentage)
CD1a HLA-DR CD83 CD86 Langerin CD68
Epid Derm Epid Derm Epid Derm Epid Derm Epid Derm Epid Derm
Non-lesional skin ;3 :11 :33 :50 $ $ $ $ $ $ $ $
Perilesional skin :24 :36 ;48 :43 ;100 ;100 ;41 $ :75 ;60 ;100 ;100
Lesional skin ;69 :38 :19 :58 ;43 :25 ;57 :0.5 ;68 :67 ;100 ;70
; Reduction, : increase, $ no variation
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intracytoplasmic organelles with a widening of intercellu-
lar space in the basal layer. Melanocytes were never
detected in any of the observed fields. The most important
ultrastructural alterations concerned Langerhans cells; they
were numerous in the basal layer, with a tendency to dis-
tribute also in the suprabasal layer. Some of them presented
an indented nucleus, a rough endoplasmic reticulum
(RER), a well developed Golgi apparatus and mitochondria
with ultrastructural alterations of their membranes. Only in
very few of them it was possible to observe the typical
Birbeck granule. There were also dendritic cells with a less
differentiated phenotype, with many mitochondria within
the cytoplasm and some of them with ultrastructural
alterations.
After nb-UVB therapy, in the non-lesional vitiligo skin
there were signs of increased melanogenesis in melano-
cytes with many melanosomes within the keratinocytes.
There were no other modifications compared to the pre-nb-
UVB treatment. Also perilesional vitiligo skin showed
some signs of melanogenesis activation: a lot of melano-
somes were observed in the epidermal-melanic unit of
basal and suprabasal layers (Fig. 5) particularly between
the basal and spinosus layer. Langerhans cells preserved all
the ultrastructural alterations observed in perilesional viti-
ligo skin, with their mitochondria partially destroyed
loosing the integrity of their membranes.
In the lesional nb-UVB-exposed skin, the epidermal
cells presented more melanosomes in their cytoplasm. As
before phototherapy the intercellular spaces were enlarged.
In their cytoplasm there were a lot of mitochondria, which
were outnumber compared to other intracytoplasmic
organelles, both in keratinocytes and in Langerhans cells.
Furthermore most of Langerhans cells were devoid of
Birbeck granules [17].
Discussion
This study focuses on the pathogenetic involvement of
dendritic cells, specifically Langerhans cells, in vitiligo. In
a previous study [17] we have demonstrated their hetero-
geneous distribution in lesional, perilesional and non-
lesional vitiligo skin. According with these results we
wanted to investigate their modifications after nb-UVB.
Fig. 1 Immunohistochemical results of non-lesional (a, d), perilesional (b, e) and lesional (c, f) of vitiligo skin before and after nb-UVB with the
main monoclonal antibodies used in the study
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The first result is about the quantitative modification of
dendritic cells in non-lesional, perilesional, and lesional
vitiligo skin after nb-UVB. In the epidermis of lesional
skin, both CD1a and Langerin were reduced of 70% (69
and 68%, respectively). This data was associated with an
increase of Langerin in the dermis of the lesional vitiligo
skin (67%). Therefore, in accordance with the ‘‘redistri-
bution of Langerhans cells’’ theory [13], we suppose that
after nb-UVB phototherapy, Langerhans cells migrate from
epidermis to dermis in order to reach the draining lymph
Fig. 2 a Epidermis of non-
lesional skin––comparison
between MoAb expression
before and after phototherapy.
b Dermis of non-lesional
skin––comparison between
MoAb expression before and
after phototherapy. c Epidermis
of perilesional skin––
comparison between MoAb
expression before and after
phototherapy. d Dermis of
perilesional skin––comparison
between MoAb expression
before and after phototherapy.
e Epidermis of lesional
skin––comparison between
MoAb expression before and
after phototherapy. f Dermis of
lesional skin––comparison
between MoAb expression
before and after phototherapy
Fig. 3 a Electron microscopy; magnification 96,000. Non-lesional
vitiligo skin pre-nb-UVB. Basal and suprabasal keratinocytes in a
well differentiated condition and many melanosomes (arrow) within
their cytoplasm. b Electron microscopy; magnification 912,000.
Non-lesional vitiligo skin pre-nb-UVB. Anchoring fibrils (arrow) and
desmosomes (asterisk) appear well preserved
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nodes. More exactly there is a reduced expression of CD86
both in lesional and perilesional vitiligo skin. CD86 in
combination with CD80 form the ‘‘B7 complex’’, which is
used by Langerhans cells as a co-stimulatory molecule to
lymphocytes for the antigen presentation process. There-
fore, the reduction of CD86 expression is indicative of an
impaired state of the functional activity of Langerhans cells
[19, 21]. Another important and new data is the depletion
of tissue macrophages after nb-UVB phototherapy. The
expression of CD68 is reduced in epidermis of lesional and
perilesional skin. On the other hand in the dermis there is a
partial decrease (70 vs. 100%) and this could be explained
as an ‘‘attenuation’’ of nb-UVB by the stratum corneum of
the skin.
The second result is related to the distribution of some
immunophenotypical markers of dendritic cells, confirmed
by both immunohistochemical and electron microscopy
data. Nb-UVB are known to reduce Langerhans cells func-
tions but they can also induce their immunophenotypical
modifications. In the immunohistochemical analysis, we
have showed a reduced expression of CD83 in lesional and
perilesional skin (in the epidermis of 45 and 100%,
respectively and also in the dermis of perilesional skin of
100%). At the same time, by electron microscopy we have
not found any morphological signs of terminal differenti-
ation of Langerhans cells. Specifically, it was not possible
to detect the presence of the typical Birbeck granule in
lesional skin. After nb-UVB exposure, in fact, there is a
replacement of Langerhans cells, which have migrated to
the dermis, by immature precursors [15]. This CD83
expression reduction, on the other hand, was not observed
in the lesional dermis of vitiligo skin where there is an
increase of 25%. A possible explanation is that in perile-
sional vitiligo dermis there is a particular dendritic subset
(as in other inflammatory conditions) [18], which is
Langerin?, CD103? and devoid of Birbeck granules. We
cannot exclude an immature immunophenotyping of this
subset of dendritic cells, which could be an explanation for
the increasing in CD83 expression. Finally according to our
data, we suggest an involvement of this dendritic subset in
the pathogenesis of vitiligo. Previous studies [12, 14, 17]
have demonstrated an increase of Langerhans cells in vit-
iligo skin without clearing the subset involved. We have
already shown in another skin disease [16] the relevance of
dendritic cells in the pathogenesis, defying their role con-
sistent with the numerous subsets. We are not able to stress
exactly which is the definitive role of these cells in the
pathogenesis of vitiligo; surely the identification of another
dendritic subset other than Langerhan cells is relevant.
In other conditions these langerin?CD103? dendritic
cells stimulate naive T cells to proliferate and produce
IFN-gamma and IL-17. This process is particularly strong
in presence of GM-CSF. They are efficient in presenting
viral antigens (especially) but they are also very efficient in
presenting skin-derived self-antigens [3]. We also found a
Fig. 4 a Electron microscopy; magnification 98,000. Perilesional
vitiligo skin pre-nb-UVB. A Langerhans cell with numerous
mitochondria. Most of them presented ultrastructural modifications:
from disruptions of their membranes (arrow) till disappearance of the
cristae (asterisk). b Electron microscopy; magnification 930,000.
Perilesional vitiligo skin pre-nb-UVB. A detail of a Langerhans cell:
Birbeck granules (arrow) in the peri-Golgian area
Fig. 5 Electron microscopy; magnification 98,000. Perilesional
vitiligo skin post-nb-UVB. Many melanosomes––all in a well
differentiated status––within basal and suprabasal keratinocytes
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particular immunophenotypical change of Langerhans cells
after nb-UVB exposure in a switch to the preferential
presentation of antigens other than peptides, probably lipid
or carbohydrate antigens. This occurrence could be better
described as ‘‘antigenic redistribution’’ of Langerhans
cells. It is particularly evident in the epidermis of perile-
sional skin, where we showed an increase of CD1a and
Langerin expression, by 24 and 75%, respectively, mole-
cules which are normally not used to present peptide
antigens, but lipidic or carbohydratic ones [11]. We can
speculate that this ‘‘antigenic redistribution’’ of Langerhans
cells is an exclusive effect of nb-UVB phototherapy,
because no other immunomodulating treatment has dem-
onstrated a similar result as far as we know.
In conclusion, our study underlines the importance of
dendritic cells, specifically Langerhans cells, in the path-
ogenesis of non-segmental vitiligo. Nb-UVB,), one of the
most used therapy for vitiligo, is effective because (next to
all the other biological activities) it reduces the number of
pre-existing Langerhans cells and redistributes the den-
dritic subsets.
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